CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,095 | -58.0% | 377,593 | -44.0% | 0.00% | -50.0% |
| Q2 2023 | $1,160,142 | +5.3% | 674,501 | -7.6% | 0.00% | 0.0% |
| Q1 2023 | $1,102,206 | +1800.4% | 729,938 | +1723.9% | 0.00% | – |
| Q3 2022 | $58,000 | -50.8% | 40,021 | -37.6% | 0.00% | – |
| Q2 2022 | $118,000 | +195.0% | 64,144 | +320.2% | 0.00% | – |
| Q1 2022 | $40,000 | -95.6% | 15,266 | -87.0% | 0.00% | -100.0% |
| Q1 2020 | $900,000 | -73.0% | 117,393 | -70.8% | 0.01% | -60.9% |
| Q4 2019 | $3,336,000 | +5554.2% | 401,426 | +4902.2% | 0.02% | – |
| Q3 2019 | $59,000 | -92.5% | 8,025 | -84.5% | 0.00% | -100.0% |
| Q4 2018 | $783,000 | -73.7% | 51,876 | -67.7% | 0.01% | -38.5% |
| Q3 2018 | $2,976,000 | +765.1% | 160,816 | +1229.1% | 0.01% | -7.1% |
| Q1 2018 | $344,000 | – | 12,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |